Trials / Completed
CompletedNCT02290093
Bowel Preparation for Colonoscopy in the Elderly
Bowel Preparation With Standard 4 Liters of PEG vs. Split-dose of 4 Liters PEG vs. Split-dose of 2 Liters PEG Containing Ascorbic Acid Solutions for Outpatient Elective Colonoscopy in the Elderly: A Randomized, Colonoscopist-blinded Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 230 (actual)
- Sponsor
- Kyunghee University Medical Center · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
The success of colonoscopy is closely related to the quality of colonic preparation. However, data regarding colonoscopy preparations in the elderly (65 years older) are scarce. Split-dosage cathartic bowel preparation are currently suggested, whereas supporting evidence is lacking in this particular group of patients. Moreover, patient tolerability is a key factor for success of bowel preparation in the aged people. The purpose of this study is to compare the bowel cleansing efficacy and patient compliance of following bowel preparation methods prior to elective outpatient colonoscopy in the elderly: (1) standard preparation of 4 liters (L) PEG-3350 solution on the night before colonoscopy, (2) split-dose of 4L PEG-3350 solution, and (3) split-dose of reduced volume \[2L\] PEG-3350 containing ascorbic acid solution.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Standard full-volume PEG | Subjects will be asked to take 4L of PEG-3350 solution the day prior to procedure. |
| DRUG | Split-dose full-volume PEG | Subjects will be asked to take 2L of PEG-3350 solution the day prior to procedure, followed by another 2L of PEG-3350 solution on the day of the procedure. |
| DRUG | Split-dose low-volume PEG | Subjects will be asked to take 1L of PEG-3350 containing ascorbic acid solution the day prior to procedure, followed by another 1L of PEG-3350 containing ascorbic acid solution on the day of the procedure. |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2015-09-01
- Completion
- 2015-12-01
- First posted
- 2014-11-13
- Last updated
- 2016-02-24
Locations
3 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02290093. Inclusion in this directory is not an endorsement.